Hyperuricemia in kidney transplantation

Contributions to Nephrology

Volumn 147, Issue , 2005, Pages 124-131

  Perico, Norberto ^a,c   Codreanu, Igor ^a,b,d   Caruso, Mariarosa ^a   Remuzzi, Giuseppe ^a  

^a OSPEDALI RIUNITI   (Italy)

^b Republican Clinical Hospital   (Moldova)

^c Center for Research on Organ Transplant 'Chiara Cucchi de Alessandri and Gilberto Crespi'   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

CHRONIC DISEASE; GRAFT REJECTION; HUMAN; HYPERURICEMIA; KIDNEY TRANSPLANTATION; REVIEW;

CHRONIC DISEASE; CYCLOSPORINE; GRAFT REJECTION; HUMANS; HYPERURICEMIA; KIDNEY TRANSPLANTATION;

EID: 16644374441     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (46)

1. Hariharan S: Long-term kidney transplant survival. Am J Kidney Dis 2001;38:S44-S50.
2. Kendrick E: Cardiovascular disease and the renal transplant recipient. Am J Kidney Dis 2001;38: S36-S43.
3. Remuzzi G, Perico N: Protecting single-kidney allografts from long-term function deterioration. J Am Soc Nephrol 1998;9:1321-1332.
4. Ahn KJ, Kim YS, Lee HC, Park K, Huh KB: Cyclosporine-induced hyperuricemia after renal transplant: Clinical characteristics and mechanisms. Transplant Proc 1992;24:1391-1392.
5. Delaney V, Sumrani N, Daskalakis P, Hong JH, Sommer BG: Hyperuricemia and gout in renal allograft recipients. Transplant Proc 1992;24:1773-1774.
6. West C, Carpenter BJ, Hakala TR: The incidence of gout in renal transplant recipients. Am J Kidney Dis 1987;10:369.
7. Peeters P, Sennesael J: Low-back pain caused by spinal tophus: A complication of gout in a kidney transplant recipient. Nephrol Dial Transplant 1998;13:3245-3247.
8. Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo A: Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 1999;33:225-234.
9. Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, Hosoyamada M, Takeda M, Sekine T, Igarashi T, Matsuo H, Kikuchi Y, Oda T, Ichida K, Hosoya T, Shimokata K, Niwa T, Kanai Y, Endou H: Molecular identification of a renal urate-anion exchanger that regulates blood urate levels. Nature 2002;417:447-452.
10. Roch-Ramel F, Guisan B, Diezi J: Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles. J Pharmacol Exp Ther 1997;280:839-845.
11. Clive DM: Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol 2000;11: 974-979.
12. Gores PF, Fryd DS, Sutherland DE, Najarian JS, Simmons RL: Hyperuricemia after renal transplantation. Am J Surg 1988;156:397-400.
13. Tiller DJ, Hall BM, Horvarth JS, Duggin GG, Thompson JF, Sheil AGR: Gout and hyperuricaemia in patients on cyclosporine and diuretics. Lancet 1985;1:453.
14. Holms EW, Kelley WN, Wynagaarden JB: The kidney and uric acid excretion in man. Kidney Int 1972;2:115-118.
15. Better OS: Tubular dysfunction following kidney transplantation. Nephron 1980;25:209-213.
16. Schmidt P, Zazgornik J, Kopsa H: Hypouricemia after renal transplantation. N Engl J Med 1973; 289:1373.
17. Vertuno LL, Preuss HG, Argy WP Jr, Schreiner GE: Fanconi syndrome following homotransplantation. Arch Intern Med 1974;133:302-305.
18. Marcén R, Gallego N, Orofino L, Sabater J, Pascual J, Teruel JL, Liano F, Ortuno J: Influence of cyclosporin A on renal handling of urate. Transplant Int 1992;5:S81-S83.
19. Chapman JR, Griffiths D, Harding NGL, Morris PJ: Reversibility of cyclosporin nephrotoxicity after three months treatment. Lancet 1985;1:128-130.
20. Cohen SL, Boner G, Rosenfeld JB, Shmueli D, Sperling O, Yusim A, Todd-Pokroped A, Shapira Z: The mechanism of hyperuricaemia in cyclosporin-treated renal transplant recipients. Transplant Proc 1987;19:1829-1830.
21. Marcén R, Gallego N, Orofino L, Gamez C, Estepa MR, Teruel JL, Ortuno J: Impairment of tubular secretion of urate in renal transplant patients on cyclosporine. Nephron 1995;70:307-313.
22. Laine J, Holmberg C: Tubular effects of cyclosporine in pediatric renal transplant recipients. Transplant Proc 1996;28:2104-2106.
23. Lin HY, Rocher LL, McQuillan MA, Schmaltz S, Palella TD, Fox IH: Cyclosporine-induced hyperuricemia and gout. N Engl J Med 1989;21:287-292.
24. Kahl LE, Thompson ME, Griffith BP: Gout in the heart transplant recipient: Physiological puzzle and therapeutic challenge. Am J Med 1989;87:289.
25. Palestine AG, Nussenblatt RS, Chan CC: Side effects of systemic cyclosporine in patients not undergoing transplantation. Am J Med 1984;77:652-656.
26. Ochiai T, Ishibashi M, Fukao K, Takahashi K, Endo T: Japanese multicenter studies of FK 506 in renal transplantation. Transplant Proc 1995;27:50-52.
27. Berger L, Yu T: Renal function in gout: IV: An analysis of 524 gouty subjects including long-term follow-up studies. Am J Med 1975;59:605-613.
28. Talbott JH, Terplan KL: The kidney in gout. Medicine 1960;39:405-467.
29. Nickeleit V, Mihatsch MJ: Uric acid nephropathy and end stage renal disease: Review of a non-disease. Nephrol Dial Transplant 1997;12:1832-1838.
30. Syrjanen J, Mustonen J, Pasternak A: Hypertriglyceridemia and hyperuricemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant 2000;15:34-42.
31. Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita S: Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 2001;24: 691-697.
32. Mazzali M, Kanellis J, Han L, Feng L, Chen Q, Kang DH, Watanabe S, Nakagawa T, Lan HY, Johnson RJ: Hyperuricemia induces a primary arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002;282:F991-F997.
33. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ: A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002;13:2888-2897.
34. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003;41:1183-1190.
35. Gerhardt U, Grobe Huttmann M, Hohage H: Influence of hyperglycemia and hyperuricemia on long-term transplant survival in kidney transplant recipients. Clin Transplant 1999;13: 375-379.
36. Remuzzi G, Perico N: Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney Int 1995;48:S70-S74.
37. Gotti E, Perico N, Perna A, Gaspari F, Cattaneo D, Caruso R, Ferrari S, Stucchi N, Marchetti G, Abbate M, Remuzzi G: Renal transplantation: Can we reduce calcineurin inhibitor/stop steroids? Evidence based on protocol biopsy findings. J Am Soc Nephrol 2003;14:755-766.
38. Mazzali M, Kim YG, Suga SI, Gordon KL, Kang DH, Jefferson JA, Hughes J, Kivlighn SD, Lan HY, Johnson RJ: Hyperuricemia exacerbates chronic cyclosporine nephropathy. Transplantation 2001; 71:900-905.
39. Kannel WB: Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study. J Clin Epidemiol 1988;41:237-242.
40. Klein RN: Serum uric acid: Its relationship to coronary heart disease risk factors and cardiovascular disease: Evans County, Georgia. Arch Intern Med 1973;132:401-410.
41. Jossa F, Farinaro E, Panico S, Krogh V, Celentano E, Galasso R, Mancini M, Trevisan M: Serum uric acid and hypertension: The Olivetti Heart Study. J Hum Hypertens 1994;8:677-681.
42. Culleton BF, Larson MG, Kannel WB, Levy D: Serum uric acid and risk of cardiovascular disease and mortality: The Framingham Heart Study. Ann Intern Med 1999;31:7-13.
43. Fang J, Alderman MH: Serum uric acid and cardiovascular mortality: The NHANES I epidemiologic follow-up study, 1971-1992. JAMA 2000;283:2404-2410.
44. Komhoff M, Grone HJ, Klein T, Seyberth HW, Nusing RM: Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: Implications for renal function. Am J Physiol 1997;272: F460-F468.
45. Jacobs F, Mamzer-Bruneel MF, Skhiri H, Thervet E, Legendre C, Kreis H: Safety of the mycophenolate mofetil-allopurinol combination in the kidney transplant recipients with gout. Transplantation 1997;64:1087-1088.
46. Hollander AAMJ, van Saase JLCM, Kootte AMM, van Dorp WJ, van Bockel HJ: Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation. Lancet 1995; 345:610-614.